Aquaporin A/S (AQP.CO)
DKK 18.8
(-1.05%)
DKK 18.8
(-1.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -80.48 Million | -94.94 Million | -115.18 Million | -59.02 Million | -64.06 Million | -78.06 Million |
| Net Income | -90.39 Million | -113.39 Million | -131.04 Million | -123.35 Million | -70.62 Million | -71.57 Million |
| Depreciation & Amortization | 17.68 Million | 18.46 Million | 18.88 Million | 18.35 Million | 16.99 Million | 14.99 Million |
| Deferred income taxes | -49.98 Million | - | -621 Thousand | -39.95 Million | - | - |
| Stock-based compensation | 2.5 Million | -742 Thousand | 3.27 Million | 220 Thousand | - | -339 Thousand |
| Change in working capital | -7 Million | -6.9 Million | -6 Million | 1.73 Million | 138 Thousand | -11.62 Million |
| Other non-cash items | 46.71 Million | 7.63 Million | 323 Thousand | 83.97 Million | -10.56 Million | -6.48 Million |
| Investing Cash Flow | -12.87 Million | -11.4 Million | -9.76 Million | -16.72 Million | -22.35 Million | -14.09 Million |
| Investments in PPE | -12.78 Million | -11.13 Million | -9.7 Million | -16.75 Million | -22.48 Million | -10.7 Million |
| Acquisitions | - | - | - | - | - | -3.32 Million |
| Investment purchases | - | -273 Thousand | -63 Thousand | -4000.00 | - | -3.32 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -85 Thousand | -273 Thousand | -63 Thousand | 38 Thousand | 131 Thousand | -62 Thousand |
| Financing Cash Flow | 66.69 Million | -7.56 Million | 266.66 Million | 75.79 Million | 86.68 Million | 46.87 Million |
| Debt repayment | -4.07 Million | -1.68 Million | -28.63 Million | -11.84 Million | -32.81 Million | -49.6 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 70.76 Million | - | 295.32 Million | 66.64 Million | 122.49 Million | - |
| Other Financing Activities | 70.76 Million | -5.87 Million | -30 Thousand | 20.98 Million | -3 Million | 46.87 Million |
| Accounts receivables | -16.07 Million | -5.01 Million | -3.49 Million | -2.38 Million | 1.31 Million | -3.61 Million |
| Accounts payables | 7.38 Million | -4.04 Million | 4.55 Million | -3.25 Million | -1.35 Million | -2.38 Million |
| Inventory | -3.41 Million | 6.85 Million | -4.96 Million | 2.6 Million | -6.13 Million | -10.12 Million |
| Other working capital | 5.09 Million | -4.7 Million | -2.09 Million | 4.76 Million | 6.3 Million | 4.5 Million |
| Cash at beginning of period | 29.41 Million | 143.25 Million | 1.5 Million | 1.46 Million | 1.11 Million | 46.37 Million |
| Cash at end of period | 2.75 Million | 29.41 Million | 143.25 Million | 1.5 Million | 1.38 Million | 1.09 Million |
| Capital Expenditure | -12.78 Million | -11.13 Million | -9.7 Million | -16.75 Million | -22.48 Million | -10.7 Million |
| Effect of forex changes on cash | - | 68 Thousand | 51 Thousand | 82 Thousand | 28 Thousand | - |
| Net cash flow / Change in cash | -26.66 Million | -113.84 Million | 141.75 Million | 40 Thousand | 263 Thousand | -45.28 Million |
| Free Cash Flow | -93.26 Million | -106.07 Million | -124.89 Million | -75.78 Million | -86.55 Million | -88.76 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -21.29 Million | -21.29 Million | -90.39 Million | -23.68 Million | -23.68 Million | -21.4 Million |
| Depreciation & Amortization | - | - | 17.68 Million | 5.93 Million | 5.93 Million | - |
| Deferred income taxes | - | - | -49.98 Million | - | - | - |
| Stock-based compensation | 100 Thousand | 100 Thousand | 2.5 Million | 704 Thousand | 704 Thousand | 550 Thousand |
| Change in working capital | -13.44 Million | -3.65 Million | -7 Million | -6.02 Million | -6.02 Million | -3.6 Million |
| Other non-cash items | 5.67 Million | 4.36 Million | 46.71 Million | 2.27 Million | 2.27 Million | 3.33 Million |
| Investing Cash Flow | -2.91 Million | -2.37 Million | -12.87 Million | -3.45 Million | -3.45 Million | -3.14 Million |
| Investments in PPE | -2.91 Million | -47.5 Thousand | -12.78 Million | 2.53 Million | 2.53 Million | -3.14 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | -2000.00 |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.83 Million | -2.32 Million | -85 Thousand | -5.98 Million | -5.98 Million | -3.14 Million |
| Financing Cash Flow | 133.52 Million | 73.24 Million | 66.69 Million | -520.49 Thousand | -520.49 Thousand | -1.48 Million |
| Debt repayment | -14.22 Million | - | -4.07 Million | - | - | -1.48 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 172.36 Million | - | 70.76 Million | - | - | 70.76 Million |
| Other Financing Activities | 149.01 Million | 73.24 Million | 70.76 Million | -520.49 Thousand | -520.49 Thousand | -1.48 Million |
| Accounts receivables | - | - | -16.07 Million | -6.86 Million | -6.86 Million | - |
| Accounts payables | - | - | 7.38 Million | - | - | - |
| Inventory | - | - | -3.41 Million | -1.7 Million | -1.7 Million | - |
| Other working capital | -13.44 Million | -3.65 Million | 5.09 Million | 2.54 Million | 2.54 Million | -3.6 Million |
| Cash at beginning of period | 2 Million | - | 29.41 Million | 52.32 Million | 52.32 Million | 78.07 Million |
| Cash at end of period | 103.54 Million | 50.39 Million | 2.75 Million | 2.75 Million | 27.53 Million | 52.32 Million |
| Capital Expenditure | -2.91 Million | -47.5 Thousand | -12.78 Million | 2.53 Million | 2.53 Million | -3.14 Million |
| Effect of forex changes on cash | 8000.00 | 8000.00 | - | -11 Thousand | -11 Thousand | 9000.00 |
| Net cash flow / Change in cash | 101.54 Million | 50.39 Million | -26.66 Million | -49.56 Million | -24.78 Million | -25.75 Million |
| Free Cash Flow | -31.98 Million | -20.52 Million | -93.26 Million | -18.26 Million | -18.26 Million | -24.27 Million |
AJOT
HROWM
TRTX
ATP
IEGCF
TANLA